Q: Can I take other medications while receiving BENDEKA®?

Talk with your doctor about any medications you are taking or plan to take. Some types of medication may impact the way BENDEKA works in the body.

Q: Are there any foods I should avoid during treatment?

A healthy diet is important when you're being treated for cancer. The right diet can help you keep up your strength and energy level. But getting the right nutrition can be hard if you don’t feel well. Some people lose their appetite or have trouble eating because of side effects from chemotherapy.

Tell your health care team about any concerns you have about eating. They can help you make diet changes that will help you cope with certain side effects.

Q: Can I return to work or my normal activities?

That will depend on how you respond to your treatment. Each person responds differently. Ask your doctor what is best for you.

As you return to your daily activities, let your caregiver and friends help you. Allowing friends and family to give moral and emotional support can be very helpful during your treatment.

Q: What should I do if I am having side effects from treatment?

Get in touch with your doctor or nurse right away if you have any side effects. Don’t wait to share this information at your next office visit.

Tell your doctor if you have any side effects including; rash, facial swelling, or difficulty breathing during or soon after your infusion with BENDEKA injection. These are signs of an allergic reaction. You also should tell your doctor if you have shortness of breath, significant fatigue, bleeding, fever, or other signs of infection. Also, tell your doctor if you experience nausea, vomiting, diarrhea, or a yellow skin tone. In addition, your doctor will perform blood tests to see if you have low blood counts. These are lower-than-normal numbers of red blood cells, white blood cells, or platelets.

Q: Will I lose my hair?

In a safety evaluation from a clinical study for CLL, hair loss occurred in 1 of the 153 patients treated with bendamustine hydrochloride compared to 0 (zero) of the 143 patients treated with chlorambucil. In an NHL study, hair loss occurred in 3 of the 100 patients treated with bendamustine hydrochloride.

Try these tips to make sure you are getting the right nutrition:

  • Eat several snacks during the day, rather than 3 large meals
  • Eat protein-rich foods, such as yogurt, cereal, half a sandwich, a bowl of soup, cheese and crackers
  • Avoid foods that make side effects worse. If you have diarrhea, for example, do not eat raw fruits and vegetables. If you have a sore throat, do not eat dry snacks or acidic foods

Get to know your treatment schedule

Learn how BENDEKA is given

MORE
LESS

Approved Use

BENDEKA is indicated for the treatment of patients with

  • Chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established.

  • Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or a rituximab-containing regimen.

Important Safety Information

BENDEKA (bendamustine HCl) injection is not right for everyone, including patients with a known allergic response to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol.

BENDEKA may cause serious side effects including: low blood cell counts, infections or recurrence of infections, unexpected responses to BENDEKA when placed in your blood, sudden and severe allergic responses, kidney failure due to fast breakdown of cancer cells, other cancers, and leaking of BENDEKA out of your vein and into your surrounding skin. Some of these side effects, such as low blood counts, infections, liver injury, and severe allergic skin responses (when bendamustine HCl was given alone and in combination with other anticancer medications or allopurinol), have caused death.

Tell your doctor if you have any side effects including: rash, facial swelling, or difficulty breathing during or soon after your infusion with BENDEKA injection. These are signs of an allergic reaction. You also should tell your doctor if you have shortness of breath, significant fatigue, bleeding, bruising, fever, or other signs of infection. Also, tell your doctor if you experience nausea, vomiting, diarrhea, loss of appetite, or a yellow skin tone. In addition, your doctor will perform blood tests to see if you have low blood counts. These are lower-than-normal numbers of red blood cells, white blood cells, or platelets.

Some serious side effects may require changes in therapy, such as lowering the amount of BENDEKA given, stopping the use of BENDEKA, or waiting longer than expected between doses of BENDEKA.

BENDEKA may cause fetal harm if taken while pregnant. Women should avoid becoming pregnant or nursing while receiving BENDEKA.

Non–blood-related side effects may occur including: fever, nausea, and vomiting, diarrhea, constipation, loss of appetite, cough, headache, weight loss, difficulty breathing, rash, and mouth irritation.

Blood-related side effects may occur including: low red blood cells (oxygen-carrying cells), low platelets (blood-clotting cells), and decreased number of three different types of white blood cells (infection-fighting cells).

These are not all of the possible side effects of BENDEKA. For more information ask your healthcare provider.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information about BENDEKA, ask your doctor, or call 1-800-896-5855.

This information does not take the place of talking with your doctor for medical advice about your condition or treatment.

Please read the Full Prescribing Information.

BENDEKA® is a registered trademark of Cephalon, Inc.
©2017 Cephalon, Inc., a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd.
All rights reserved. BEN-40430 June 2017.

The information presented on this Web site is intended for US residents only.

MORE
LESS

Approved Use

BENDEKA is indicated for the treatment of patients with

  • Chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established.

  • Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or a rituximab-containing regimen.

Important Safety Information

BENDEKA (bendamustine HCl) injection is not right for everyone, including patients with a known allergic response to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol.

BENDEKA may cause serious side effects including: low blood cell counts, infections or recurrence of infections, unexpected responses to BENDEKA when placed in your blood, sudden and severe allergic responses, kidney failure due to fast breakdown of cancer cells, other cancers, and leaking of BENDEKA out of your vein and into your surrounding skin. Some of these side effects, such as low blood counts, infections, liver injury, and severe allergic skin responses (when bendamustine HCl was given alone and in combination with other anticancer medications or allopurinol), have caused death.

Tell your doctor if you have any side effects including: rash, facial swelling, or difficulty breathing during or soon after your infusion with BENDEKA injection. These are signs of an allergic reaction. You also should tell your doctor if you have shortness of breath, significant fatigue, bleeding, bruising, fever, or other signs of infection. Also, tell your doctor if you experience nausea, vomiting, diarrhea, loss of appetite, or a yellow skin tone. In addition, your doctor will perform blood tests to see if you have low blood counts. These are lower-than-normal numbers of red blood cells, white blood cells, or platelets.

Some serious side effects may require changes in therapy, such as lowering the amount of BENDEKA given, stopping the use of BENDEKA, or waiting longer than expected between doses of BENDEKA.

BENDEKA may cause fetal harm if taken while pregnant. Women should avoid becoming pregnant or nursing while receiving BENDEKA.

Non–blood-related side effects may occur including: fever, nausea, and vomiting, diarrhea, constipation, loss of appetite, cough, headache, weight loss, difficulty breathing, rash, and mouth irritation.

Blood-related side effects may occur including: low red blood cells (oxygen-carrying cells), low platelets (blood-clotting cells), and decreased number of three different types of white blood cells (infection-fighting cells).

These are not all of the possible side effects of BENDEKA. For more information ask your healthcare provider.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information about BENDEKA, ask your doctor, or call 1-800-896-5855.

This information does not take the place of talking with your doctor for medical advice about your condition or treatment.

Please read the Full Prescribing Information.